-
Suppression of membrane microvesiculation - a possible anticoagulant and anti-tumor progression effect of heparinŠuštar, Vid ...Heparins (unfractionated and low molecular weight (LMWH) heparins) primarily used as anticoagulants, were found to be effective also in slowing down the development of some types of cancer. On the ... other hand, the number of microvesicles in the peripheral blood originating from the budding of cell membranes (mostly platelets) is increased in hypercoagulabile states as well as in cancer, indicating a possible common underlying mechanism. It was hypothesized that by mediating an attractive interaction between phospholipid membranes heparin suppresses microvesiculation and thereby acts as an anticoagulant and anti-tumor agent. In this work, the effect of LMWH nadroparin on phospholipid membranes was tested in vitro in a system of giant phospholipid vesicles (GPVs) created by electroformation and observed under the phase contrast microscope. Plasma of different blood donors containing different concentrations of nadroparin was added to the suspension of GPVs to induce adhesion between GPVs. The attractive interaction between membranes wasassessed by measuring the average effective angle of contact between the adhered GPVs. It was found in healthy donors, in a donor with gastrointestinalcancer and in a donor with rheumatoid arthritis that adding therapeutic doses of nadroparin to the plasma samples enhanced adhesion of phospholipid membranes in a dose and time-dependent manner while nadroparin alone had no effect within the therapeutic concentration range. The results are in favor of the hypothesis that suppression of microvesiculation underliesboth, the anticoagulant and the anti-tumor progression effect of heparin.Vir: Blood cells, molecules & diseases. - ISSN 1079-9796 (Letn. 42, št. 3, 2009, str. 223-227)Vrsta gradiva - članek, sestavni delLeto - 2009Jezik - angleškiCOBISS.SI-ID - 25527257
Avtor
Šuštar, Vid |
Janša, Rado |
Frank Bertoncelj, Mojca |
Hägerstrand, Henry |
Kržan, Mojca, 1962- |
Iglič, Aleš, 1960- |
Kralj-Iglič, Veronika
Teme
Heparin, Low-Molecular-Weight |
Pharmacology |
Membrane Lipids |
Phospholipids |
Cell Adhesion |
Microscopy, Phase-Contrast |
Blood Donors |
Arthritis, Rheumatoid |
Drug Therapy |
Gastrointestinal Neoplasms |
Drug Therapy |
Anticoagulants |
Fosfolipidi |
Celična adhezija |
Heparin, nizke-molekularne teže |
Membranski lipidi |
Mikroskopija faznokontrastna |
Artritis revmatični |
Krvodajalci |
Antikoagulansi |
Gastrointestinalne novotvorbe

Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Faktor vpliva
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Šuštar, Vid | 29375 |
Janša, Rado | 13188 |
Frank Bertoncelj, Mojca | 28513 |
Hägerstrand, Henry | ![]() |
Kržan, Mojca, 1962- | 08095 |
Iglič, Aleš, 1960- | 04634 |
Kralj-Iglič, Veronika | 05916 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.